Griseofulvin

Product NDC
68682-519
11-digit product format
686820519
Labeler code
68682
Product ID
68682-519_ab5a4a1c-90f1-40f3-aab4-6f299a885c52
Type
HUMAN PRESCRIPTION DRUG
Nonproprietary name
Griseofulvin
Dosage form
TABLET, FILM COATED
Route
ORAL
Labeler
Oceanside Pharmaceuticals
Application
NDA050475
Marketing category
NDA AUTHORIZED GENERIC
Marketing start
2016-07-26
Marketing end
0000-00-00
Substance
GRISEOFULVIN
Active strength
125 mg/1
Pharmacologic classes
Decreased Mitosis [PE],Microtubule Inhibition [PE],Tubulin Inhibiting Agent [EPC]
NDC exclude flag
E
Listing certified through
2017-12-31
Current FDA listing
Historical FDA.report record

FDA-Initiated Inactive NDC Indexing#

NDC, Effective, Action table
NDCEffectiveActionDocumentIndexing SPLRelated label
68682-519-012020-04-27C16284748780-19d75b9d0-163c-f424-e053-dadaa90a57ce39ac6363-93bc-4e12-a7a7-667eafac42a5
68682-519-012020-01-31C16284748780-19d75b9d0-163c-f424-e053-dadaa90a57ce39ac6363-93bc-4e12-a7a7-667eafac42a5

DailyMed Billing Units#

Package NDC, Billing unit, Product NDC table
Package NDCBilling unitProduct NDCDailyMed indexing SPLSPL versionEffective
68682-519-01EA - Each68682-519f924edc1-9c5b-47e4-922c-3e41164055ea12013-02-13